Singapore company whose AI-powered software supports smart ultrasound, echo report capture and cardiovascular clinical research.
Based in Singapore, Eko.ai Pte. Ltd, which does business as US2.AI, was founded in 2017 by James Hare (CEO), Carolyn Lam and Yoran Hummel. Its machine learning software supports clinical decision-making and cardiovascular research, and guides users to capture complete echo reports on mobile devices. In April 2022 it raised USD 15 million in Series A funding co-led by HEAL Partners and IHH Healthcare Berhad, with Pappas Capital participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in